Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho Lam Chan

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nature Communications|August 25, 2018
Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanismsHo Lam Chan, Felipe Beckedorff, Yusheng Zhang, et al.
American Journal of Physiology. Cell Physiology|February 21, 2026
High Fat Diet and Obesity Each Increase Tumor Cell Proliferation and Muscle Wasting in Experimental Cancer CachexiaBrittany R Counts, Andrea Bonetto, Ho Lam Chan, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 6, 2012
Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexiaFelipe E Pedroso, Paul B Spalding, Michael C Cheung, et al.
Cancer Research|September 21, 2014
BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor developmentFeng Bai, Ho Lam Chan, Alexandria Scott, et al.
Plos Pathogens|December 28, 2019
PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environmentJulian Naipauer, Santas Rosario, Sachin Gupta, et al.
Nature Structural & Molecular Biology|November 7, 2022
Endocrine resistance and breast cancer plasticity are controlled by CoRESTLiliana Garcia-Martinez, Andrew M Adams, Ho Lam Chan, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
Genes & Development|January 29, 2024
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature Communications|August 25, 2018
Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanismsHo Lam Chan, Felipe Beckedorff, Yusheng Zhang, et al.
American Journal of Physiology. Cell Physiology|February 21, 2026
High Fat Diet and Obesity Each Increase Tumor Cell Proliferation and Muscle Wasting in Experimental Cancer CachexiaBrittany R Counts, Andrea Bonetto, Ho Lam Chan, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 6, 2012
Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexiaFelipe E Pedroso, Paul B Spalding, Michael C Cheung, et al.
Cancer Research|September 21, 2014
BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor developmentFeng Bai, Ho Lam Chan, Alexandria Scott, et al.
Plos Pathogens|December 28, 2019
PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environmentJulian Naipauer, Santas Rosario, Sachin Gupta, et al.
Nature Structural & Molecular Biology|November 7, 2022
Endocrine resistance and breast cancer plasticity are controlled by CoRESTLiliana Garcia-Martinez, Andrew M Adams, Ho Lam Chan, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
Genes & Development|January 29, 2024
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
Pageof 2